Removal of blood group A/B antigen in organs by ex vivo and in vivo administration of endo-ß-galactosidase (ABase) for ABO-incompatible transplantation

Transplant Immunology

Volumn 20, Issue 3, 2009, Pages 132-138

  Kobayashi, Takaaki ^a   Liu, DaGe ^a   Ogawa, Haruko ^b   Miwa, Yuko ^a   Nagasaka, Takaharu ^c   Maruyama, Shoichi ^a   Li, Yu Teh ^d   Onishi, Akira ^e   Iwamoto, Masaki ^f   Kuzuya, Takafumi ^a   Kadomatsu, Kenji ^a   Uchida, Kazuharu ^c   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^f Prime Tech Ltd   (Japan)

Author keywords

ABO incompatibility; Antibody mediated rejection; Blood type A B antigen; Endo beta galactosidase

Indexed keywords

BETA GALACTOSIDASE; BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BABOON; BLOOD GROUP ABO INCOMPATIBILITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CRYOPRESERVATION; ERYTHROCYTE; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; GLOMERULUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LIVER BIOPSY; LIVER SINUSOID; NONHUMAN; ORGAN PERFUSION; ORGAN PRESERVATION; PRIORITY JOURNAL;

ABO BLOOD-GROUP SYSTEM; ANIMALS; BETA-GALACTOSIDASE; BLOOD GROUP INCOMPATIBILITY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TRANSPLANTATION; LIVER; LIVER TRANSPLANTATION; PAPIO ANUBIS; RECOMBINANT PROTEINS;

EID: 57549116899     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.09.007     Document Type: Article

References (30)

1. Cook D.J., Graver B., and Terasaki P.I. ABO incompatibility in cadaver donor kidney allografts. Transplant Proc 19 6 (1987) 4549-4552
2. Takahashi K., Saito K., Takahara S., et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4 6 (2004) 1089-1096
3. Sonnenday C.J., Warren D.S., Cooper M., et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 4 8 (2004) 1315-1322
4. Stegall M.D., Dean P.G., and Gloor J.M. ABO-incompatible kidney transplantation. Transplantation 78 5 (2004) 635-640
5. Montgomery R.A., and Locke J.E. ABO-incompatible transplantation: less may be more. Transplantation 84 12 Suppl (2007) S8-9
6. Tanabe K. Japanese experience of ABO-incompatible living kidney transplantation. Transplantation 84 12 Suppl (2007) S4-7
7. Sanchez-Urdazpal L., Batts K.P., and Gores G.J. Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg 218 2 (1993) 152-158
8. Egawa H., Oike F., and Buhler L. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 77 3 (2004) 403-411
9. Miyata R., Shimazu M., and Tanabe M. Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation. Liver Transpl 13 10 (2007) 1455-1462
10. Egawa H., Teramukai S., Haga H., Tanabe M., Fukushima M., and Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 47 1 (2008) 143-152
11. Testa G., Vidanovic V., and Chejfec G. Adult living-donor liver transplantation with ABO-incompatible grafts. Transplantation 85 5 (2008) 681-686
12. Pratschke J., and Tullius S.G. Promising recent data on ABO incompatible liver transplantation: restrictions may apply. Transpl Int 20 8 (2007) 647-648
13. Hasegawa Y., Kato Y., and Kaneko M.K. Neutralization of blood group A-antigen by a novel anti-A antibody: overcoming ABO-incompatible solid-organ transplantation. Transplantation 85 3 (2008) 378-385
14. Liu Q.P., Sulzenbacher G., and Yuan H. Bacterial glycosidases for the production of universal red blood cells. Nat Biotechnol 25 4 (2007) 454-464
15. Olsson M.L., and Clausen H. Modifying the red cell surface: towards an ABO-universal blood supply. Br J Haematol 140 1 (2008) 3-12
16. Kobayashi T., Liu D., and Ogawa H. Alternative strategy for overcoming ABO incompatibility. Transplantation 83 9 (2007) 1284-1286
17. Anderson K.M., Ashida H., Maskos K., Dell A., Li S.C., and Li Y.T. A clostridial endo-beta-galactosidase that cleaves both blood group A and B glycotopes: the first member of a new glycoside hydrolase family, GH98. J Biol Chem 280 9 (2005) 7720-7728
18. Ogawa H., Muramatsu H., and Kobayashi T. Molecular cloning of endo-beta-galactosidase C and its application in removing alpha-galactosyl xenoantigen from blood vessels in the pig kidney. J Biol Chem 275 25 (2000) 19368-19374
19. Liu D., Kobayashi T., and Yokoyama I. Enzymatic removal of alphaGal antigen in pig kidneys by ex vivo and in vivo administration of endo-beta-galactosidase C. Xenotransplantation 9 3 (2002) 228-236
20. Miki Y., Maruyama S., and Liu D. In vivo gene transfer of endo-beta-galactosidase C removes alpha Gal antigen on erythrocytes and endothelial cells of the organs. Xenotransplantation 11 5 (2004) 444-451
21. Kobayashi T., and Cooper D.K. Anti-Gal, alpha-Gal epitopes, and xenotransplantation. Sub-cell Biochem 32 (1999) 229-257
22. Oriol R., Le Pendu J., and Mollicone R. Genetics of ABO, H, Lewis, X and related antigens. Vox Sang 51 3 (1986) 161-171
23. Miwa Y., Kobayashi T., and Nagasaka T. Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation?. Xenotransplantation 11 3 (2004) 247-253
24. Zhu A., and Hurst R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 9 6 (2002) 376-381
25. Morgan B.P., Berg C.W., and Harris C.L. "Homologous restriction" in complement lysis: roles of membrane complement regulators. Xenotransplantation 12 4 (2005) 258-265
26. Galili U. Anti-gal antibody prevents xenotransplantation. Sci Med 5 5 (1998) 28-37
27. Kobayashi T., Yokoyama I., and Morozumi K. Comparative study of the efficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis. Xenotransplantation 7 2 (2000) 101-108
28. Kobayashi T., Liu D., and Miwa Y. Immunogenicity of cloned pig cells expressing only 1% of alpha Gal antigens. Xenotransplantation 12 5 (2005) 375
29. Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant 19 Suppl 14 (2005) 76-85
30. Ogawa H., Mohiuddin M.M., Yin D.P., Shen J., Chong A.S., and Galili U. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation 77 3 (2004) 366-373